Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin-5c is a member of the class V myosin family and functions as a motor protein involved in actin-dependent intracellular transport, especially in epithelial and glandular tissues[1][2][3][5]. It is composed of two heavy chains, each with a motor domain, a neck domain with multiple IQ motifs that bind calmodulin or myosin light chains, a coiled-coil dimerization domain, and a globular tail domain that interacts with cargo adaptors, often Rab family proteins[1][2]. MYO5C is particularly abundant in secretory and epithelial cells (e.g., pancreas, colon, mammary, thyroid)[2][3]. Unlike MYO5A and MYO5B, MYO5C operates as a low duty ratio, non-processive motor, suggesting it is adapted for ensemble-based cargo transport or organelle tethering, rather than individual, long-distance processive transport[1][2][4]. It plays important roles in vesicle transport, secretory granule trafficking, and membrane receptor localization (e.g., transferrin receptor, Rab8, Rab27b)[3][5]. The small molecule pentabromopseudilin is a known inhibitor of MYO5C motor activity, acting allosterically[1][2]. Currently, MYO5C is not recognized as a therapeutic drug target or associated with direct disease modulation, but it is critical for secretory processes in glandular and epithelial cells[2][3][5].
Allosteric inhibition of motor function by binding near the actin and nucleotide binding site (PBP)[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin-5c (MYO5C).